curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study

by palligoelme@gmail.com | Jan 14, 2026 | Clinical Trials

​ Conditions: Lung Non-Small Cell Carcinoma Interventions: Other: Non-Interventional Study Sponsors: University of Southern California; National Cancer Institute (NCI); Bristol-Myers Squibb Not yet recruiting Conditions: Lung Non-Small Cell Carcinoma Interventions:...

Experience of Staying in Intensive Care and Impact on Quality of Life

by palligoelme@gmail.com | Jan 14, 2026 | Clinical Trials

​ Conditions: Post-traumatic Stress Disorder Sponsors: University Hospital, Strasbourg, France Recruiting Conditions: Post-traumatic Stress Disorder Sponsors: University Hospital, Strasbourg, France Recruiting 

Positional Effects on Lung Ventilation and Perfusion in Obesity: An EIT Study

by palligoelme@gmail.com | Jan 14, 2026 | Clinical Trials

​ Conditions: Obesity (Disorder); Ventilation Homogeneity; Perfusion; Ventilation Perfusion Mismatch; Position Differences; Electrical Impedance Tomography (EIT) Interventions: Other: Standardized body positioning Sponsors: Koç University Active, not...

Posturography Rehabilitation and Pelvic Floor Training on Urinary Incontinence in Women

by palligoelme@gmail.com | Jan 13, 2026 | Clinical Trials

​ Conditions: Urinary Incontinence Interventions: Behavioral: Pelvic Floor Muscle Training; Behavioral: Posturography Rehabilitation Sponsors: Mohammed V University in Rabat Recruiting Conditions: Urinary Incontinence Interventions: Behavioral: Pelvic Floor Muscle...

A Phase II Study Evaluating Andamertinib in Patients With Locally Advanced or Metastatic NSCLC Harboring EGFR PACC or EGFR L861Q Mutations.

by palligoelme@gmail.com | Jan 13, 2026 | Clinical Trials

​ Conditions: Non-Small-Cell Lung Cancer Interventions: Drug: PLB1004 Sponsors: Avistone Biotechnology Co., Ltd. Not yet recruiting Conditions: Non-Small-Cell Lung Cancer Interventions: Drug: PLB1004 Sponsors: Avistone Biotechnology Co., Ltd. Not yet...
« Older Entries
Next Entries »

Recent Posts

  • Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test
  • Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients
  • Clinical Features and Outcomes of VZV CNS Infections
  • Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)
  • A Multimodal Prospective Cohort Study of Parkinsonism

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®